Obermatt

Emami

NSI:EMAMILTD · INE548C01032
Personal ProductsMedium

360

73
EV / EBIT19
Price / Owner Earnings39
Owner Earnings Yield64
Dividend Yield73
Price/Sales17
EV / Gross Profit14
Price/Book1
Return on Capital85
Cash Return on Capital83
Return on Equity84
EBIT Margin87
Gross Profitability81
Cash Conversion34
Owner Earnings Margin98
Sales growth73
Profit Growth78
Long-Term EPS Growth62
Reinvestment93
Price momentum11
Debt load74
Refinancing33
Debt Payback100
Liquidity79
Analyst ratings58
Opinion Changes50
Price Target Upside70
Market mood95
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Emami clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryIndia
IndustryPersonal Products
SizeMedium
TypePublic Company
ExchangeBSE
Founded1983
Employees2,351
ISININE548C01032
Last UpdateApr 2, 2026
Index & Theme
Pain ManagementNutraceuticalOrganicAlternative MedicineLifestyleFast-Moving Consumer GoodsConsumer GoodsHealth CareManufacturing

Description

Emami Limited operates in the consumer goods sector, primarily focusing on personal care and healthcare products. The company offers portfolio, which includes cosmetics, skincare, and wellness items. Business Segments The company’s business operati…

Analysis

Quality compounder

Emami Limited earns the quality_compounder label: good underlying economics priced fairly, with no obvious bargain or excess.

On valuation, the picture is fair. The owner-earnings multiple stands at 17.4×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 4% a year, against analyst forecasts of 7%. The price, in other words, assumes less than the experts do.

Growth is moderate; the safety picture is sturdy. The company scores 10/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
77
2023202420252026

All-time high

94

Jan 2024

All-time low

55

Mar 2026

Average rank

73

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
17
44
49
37
Price/Earnings
23
56
57
46
Price/Book
1
21
22
23
Dividend Yield
73
77
81
72
Value (overall)
20
61
67
49

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Emami with its peers
Empro Group
NAQ:EMPG
42
CountryMalaysia
IndustryPersonal Products
SizeSmall
Full Stock Analysis →
Metro Healthcare Indonesia
JKT:CARE
21
CountryIndonesia
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Praram 9 Hospital
SET:PR9
95
CountryThailand
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Murni Sadar
JKT:MTMH
24
CountryIndonesia
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Master Style
SET:MASTER
63
CountryThailand
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Fine Organic Industries
NSI:FINEORG
54
CountryIndia
IndustryChemicals
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →